Endothéline (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Endothéline" in French language version.

refsWebsite

Global rank French rank

2ahajournals.org

3,608^th place

659^th place

1ahjonline.com

low place

1nature.com

234^th place

147^th place

1nih.gov

4^th place

12^th place

1onlinejacc.org

low place

2,587^th place

1ama-assn.org

3,257^th place

1,028^th place

1nejm.org

2,374^th place

298^th place

1oxfordjournals.org

1,389^th place

508^th place

1doi.org

2^nd place

3^rd place

1elsevier.com

610^th place

265^th place

1thelancet.com

2,393^rd place

506^th place

ahajournals.org

circ.ahajournals.org

Naomi S, Iwaoka T, Disashi T et Als. Endothelin-1 inhibits endothelin-converting enzyme-1 expression in cultured rat pulmonary endothelial cells, Circulation, 1998;97:234–236

circres.ahajournals.org

Ito H, Hirata Y, Hiroe M et Als. Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes, Circ Res, 1991;69:209–215

ahjonline.com

Dupuis J, Cernacek P, Tardif JC et Als. Reduced pulmonary clearance of endothelin-1 in pulmonary hypertension, Am Heart J, 1998;135:614–620

ama-assn.org

jama.ama-assn.org

McMurray JJ, Teerlink JR, G Cotter, Effects of tezosentan on symptoms and clinical outcomes in patients With acute heart failure: The VERITAS randomized controlled trials, JAMA, 2007;298:2009-2019

doi.org

dx.doi.org

(en) Hiddo J L Heerspink, Jai Radhakrishnan, Charles E Alpers et Jonathan Barratt, « Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial », The Lancet,‎ avril 2023, S014067362300569X (DOI 10.1016/S0140-6736(23)00569-X, lire en ligne, consulté le 2 avril 2023)

elsevier.com

linkinghub.elsevier.com

(en) Hiddo J L Heerspink, Jai Radhakrishnan, Charles E Alpers et Jonathan Barratt, « Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial », The Lancet,‎ avril 2023, S014067362300569X (DOI 10.1016/S0140-6736(23)00569-X, lire en ligne, consulté le 2 avril 2023)